These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion. Yoshida A, Wakai S, Ryo E, Miyata K, Miyazawa M, Yoshida KI, Motoi T, Ogawa C, Iwata S, Kobayashi E, Watanabe SI, Kawai A, Mori T. Am J Surg Pathol; 2019 Dec; 43(12):1622-1630. PubMed ID: 31305268 [Abstract] [Full Text] [Related]
6. EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location. Kao YC, Sung YS, Zhang L, Chen CL, Vaiyapuri S, Rosenblum MK, Antonescu CR. Am J Surg Pathol; 2017 Apr; 41(4):482-490. PubMed ID: 28009602 [Abstract] [Full Text] [Related]
13. Brain parenchymal angiomatoid fibrous histiocytoma and spinal myxoid mesenchymal tumor with FET: CREB fusion, a spectrum of the same tumor type. Kim NR, Kim SI, Park JW, Park CK, Chung CK, Choi SH, Yun H, Park SH. Neuropathology; 2022 Aug; 42(4):257-268. PubMed ID: 35730186 [Abstract] [Full Text] [Related]
14. Expanding the Spectrum of EWSR1::CREM Fusion Tumors: An Unusual Pediatric Intranasal Myxoid Tumor. Koh S, Punjabi LS, Chang KTE, Wei Yang Teo N, Ee Hoon Teo C, Soh SY, Kun Kiaang Tan H. Pediatr Dev Pathol; 2024 Aug; 27(1):90-95. PubMed ID: 37818644 [Abstract] [Full Text] [Related]